Valuation: DexCom, Inc.

Capitalization 22.6B 19.3B 17.68B 16.72B 30.96B 2,163B 31.12B 211B 81.98B 1,026B 84.8B 83.02B 3,568B P/E ratio 2026 *
24.1x
P/E ratio 2027 * 20.3x
Enterprise value 22.14B 18.91B 17.32B 16.38B 30.33B 2,119B 30.48B 206B 80.3B 1,005B 83.07B 81.33B 3,495B EV / Sales 2026 *
4.24x
EV / Sales 2027 * 3.64x
Free-Float
93.28%
Yield 2026 *
-
Yield 2027 * -
1 day-4.20%
1 week-2.97%
Current month-1.65%
1 month-7.21%
3 months-16.35%
6 months-1.93%
Current year-11.75%
1 week 58.42
Extreme 58.425
61.46
1 month 56.72
Extreme 56.72
65.29
Current year 56.72
Extreme 56.72
75.98
1 year 54.11
Extreme 54.11
89.98
3 years 54.11
Extreme 54.11
142
5 years 54.11
Extreme 54.11
164.86
10 years 10.66
Extreme 10.655
164.86
Manager TitleAgeSince
Chief Executive Officer 47 01/01/2026
Director of Finance/CFO 46 19/03/2021
Chief Tech/Sci/R&D Officer - 01/05/2024
Director TitleAgeSince
Chairman 68 30/07/2018
Director/Board Member 67 20/11/2009
Director/Board Member 47 01/01/2026
Change 5d. change 1-year change 3-years change Capi.($)
-4.20%-2.97%-30.36%-51.87% 22.6B
-0.62%-2.86%-35.04%-24.13% 146B
-0.79%-1.79%-10.46%-14.26% 97.84B
-0.04%+0.58%+54.24%+79.68% 58.66B
-2.01%+1.16%-8.36%+49.53% 49.75B
-2.26%-0.40%-17.77%-42.90% 39.73B
+0.42%-7.86% - - 32.73B
-3.10%-3.25%+40.08%-16.00% 21.36B
+0.12%-1.57%-8.67%+0.12% 20.7B
+0.75%-1.76%-19.96%-34.07% 18.32B
Average -0.96%-1.94%-4.03%-5.99% 50.77B
Weighted average by Cap. -0.46%-1.94%-9.38%-3.41%

Financials

2026 *2027 *
Net sales 5.23B 4.46B 4.09B 3.87B 7.16B 500B 7.2B 48.7B 18.96B 237B 19.61B 19.2B 825B 5.85B 4.99B 4.58B 4.33B 8.01B 560B 8.05B 54.49B 21.21B 266B 21.94B 21.48B 923B
Net income 964M 823M 754M 713M 1.32B 92.23B 1.33B 8.98B 3.5B 43.77B 3.62B 3.54B 152B 1.17B 996M 912M 862M 1.6B 112B 1.61B 10.86B 4.23B 52.95B 4.37B 4.28B 184B
Net Debt -462M -394M -361M -342M -633M -44.21B -636M -4.3B -1.68B -20.98B -1.73B -1.7B -72.92B -1.34B -1.14B -1.05B -991M -1.83B -128B -1.84B -12.48B -4.86B -60.83B -5.03B -4.92B -211B
Logo DexCom, Inc.
DexCom, Inc. specializes in the design, manufacture and marketing of continuous glucose monitoring (CGM) systems for people with diabetes and healthcare providers. The company provides an implantable device for continuous measurement of blood glucose levels and an external transmitter to which the sensor transmits glucose levels at specified intervals. The United States accounts for 71.5% of net sales.
Employees
11,050
Date Price Change Volume
13/05/26 58.57 $ -4.20% 7,032,757
12/05/26 61.14 $ +3.05% 6,099,682
11/05/26 59.33 $ -2.11% 5,272,514
08/05/26 60.61 $ -0.49% 4,217,962
07/05/26 60.91 $ +0.91% 5,080,786
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
58.57USD
Average target price
83.28USD
Spread / Average Target
+42.19%

Quarterly revenue - Rate of surprise